BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31832406)

  • 1.
    Anayama T; Taguchi M; Tatenuma T; Okada H; Miyazaki R; Hirohashi K; Kume M; Matsusaki K; Orihashi K
    World J Clin Cases; 2019 Dec; 7(23):4036-4043. PubMed ID: 31832406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Cell-Free and Concentrated Ascites Reinfusion Therapy for Palliative Care in a Patient with Malignant Pleural Mesothelioma: A Case Report.
    Hisakane K; Ohmatsu H; Umemura S; Kirita K; Matsumoto S; Yoh K; Niho S; Goto K
    J Nippon Med Sch; 2017; 84(5):231-236. PubMed ID: 29142184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takami K; Morinaga K; Takano T; Kobayashi H
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):355-62. PubMed ID: 19131921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
    Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
    Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful analysis of anticancer drug sensitivity by CD-DST using pleural fluid and ascites from patients with advanced ovarian cancer: case reports.
    Kawaguchi M; Banno K; Susumu N; Yanokura M; Kuwabara Y; Hirao N; Tsukazaki K; Nozawa S
    Anticancer Res; 2005; 25(5):3547-51. PubMed ID: 16101178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell-Free Ascites Reinfusion Therapy(CART)Modified by Keisuke Matsusaki(KM-CART)at Our Hospital].
    Iwaki R; Shindo K; Kawahara H; Nanba N; Kuramoto Y; Beppu T; Uesugi T; Tanaka Y; Uesugi Y
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2165-2167. PubMed ID: 30692319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer.
    Maeda O; Ando T; Ishiguro K; Watanabe O; Miyahara R; Nakamura M; Funasaka K; Kazuhiro F; Ando Y; Goto H
    Mol Clin Oncol; 2014 Nov; 2(6):1103-1106. PubMed ID: 25279205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
    Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
    Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.
    Nagata Y; Kato K; Miyamoto T; Hirano H; Shoji H; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Matsushita H; Nagashima K; Saruta M; Boku N
    Support Care Cancer; 2020 Dec; 28(12):5861-5869. PubMed ID: 32253601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant peritoneal mesothelioma with massive ascites as the first symptom: A case report.
    Huang X; Hong Y; Xie SY; Liao HL; Huang HM; Liu JH; Long WJ
    World J Clin Cases; 2022 Oct; 10(28):10317-10325. PubMed ID: 36246798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of fever in cell-free and concentrated ascites reinfusion therapy is not related to the primary disease or nature of ascites.
    Fukunaga S; Egawa M; Ito T; Tanabe K
    J Artif Organs; 2024 Jun; 27(2):138-145. PubMed ID: 37178240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy.
    Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
    Ther Apher Dial; 2020 Feb; 24(1):90-95. PubMed ID: 31157953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility, efficacy, and safety of cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites.
    Matsusaki K; Orihashi K
    Artif Organs; 2020 Oct; 44(10):1090-1097. PubMed ID: 32242939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of a new malignant peritoneal mesothelioma cell line, KOG-1, from the ascitic fluid of a patient with pemetrexed chemotherapy resistance.
    Akahane T; Hirasawa A; Imoto I; Okubo A; Itoh M; Nanki Y; Yoshihama T; Tominaga E; Aoki D
    Hum Cell; 2020 Jan; 33(1):272-282. PubMed ID: 31583526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.
    Yamagami W; Banno K; Kawaguchi M; Yanokura M; Kuwabara Y; Hirao N; Susumu N; Tsukazaki K; Aoki D
    Chemotherapy; 2007; 53(2):137-41. PubMed ID: 17308380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.
    Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
    Int J Clin Oncol; 2015 Jun; 20(3):623-8. PubMed ID: 25239690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
    Matsusaki K
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Effective Palliative Care with CART for Refractory Ascites Associated with Cancerous Peritonitis of Gastric Cancer].
    Kawada J; Nishino M; Hata T; Ogino T; Hoshino H; Okano M; Nagai K; Kim Y; Okuyama M; Tsujinaka T
    Gan To Kagaku Ryoho; 2018 Apr; 45(4):700-702. PubMed ID: 29650840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free and concentrated ascites reinfusion therapy for refractory massive cardiac ascites in an adult with single ventricle haemodynamics: a case report.
    Tsukishiro Y; Yamamoto H; Masumoto A; Takaya T
    Eur Heart J Case Rep; 2023 Mar; 7(3):ytad081. PubMed ID: 36895305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.